<DOC>
	<DOCNO>NCT00068445</DOCNO>
	<brief_summary>RATIONALE : Lamotrigine may effective reduce pain , numbness , tingle , symptoms peripheral neuropathy . It yet know whether lamotrigine effective treat peripheral neuropathy cause chemotherapy . PURPOSE : This randomized phase III trial study well lamotrigine work reduce pain , numbness , tingle , symptoms peripheral neuropathy cause chemotherapy patient cancer .</brief_summary>
	<brief_title>Lamotrigine Treating Peripheral Neuropathy Caused Chemotherapy Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy lamotrigine v placebo reduce pain symptom chemotherapy-induced peripheral neuropathy patient cancer . - Compare symptom distress , mood state , functional ability , overall quality life patient treat agent . - Determine toxic effect lamotrigine patient . OUTLINE : This randomize , placebo-controlled , double-blind study . Patients stratify accord neurotoxic chemotherapy receive ( taxanes vs platinum-based compound vs vinca alkaloid vs combination v ) , status neurotoxic chemotherapy ( actively receive therapy v discontinue complete ) , duration pain neuropathy symptom ( 1-3 month v 3-6 month v 6 month ) . Patients randomize 1 2 treatment arm .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis cancer Received , currently receive , neurotoxic chemotherapy , include follow : Taxanes ( e.g. , paclitaxel docetaxel ) Platinumbased compound ( e.g. , carboplatin , cisplatin , oxaliplatin ) Vinca alkaloid ( e.g. , vincristine vinblastine ) Experiencing pain symptom peripheral neuropathy least 1 month attribute chemotherapy Average daily pain rating least 4 10 OR Peripheral neuropathy least grade 1 3 use ECOG sensory neuropathy rating PATIENT CHARACTERISTICS : Age 18 Life expectancy At least 6 month Hepatic Bilirubin &lt; 2 time upper limit normal ( ULN ) Renal Creatinine â‰¤ 1.5 time ULN Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No prior allergic reaction intolerance lamotrigine No extreme difficulty swallow pill No identified cause painful paresthesia precede chemotherapy , include follow : Radiation malignant plexopathy Lumbar cervical radiculopathy Preexisting peripheral neuropathy another etiology , follow : Cyanocobalamin deficiency AIDS Monoclonal gammopathy Diabetes Heavy metal poison amyloidosis Syphilis Hyperthyroidism hypothyroidism Inherited neuropathy No significant psychiatric illness ( e.g. , mania , psychosis , schizophrenia ) would preclude study participation Able complete questionnaire PRIOR CONCURRENT THERAPY : Chemotherapy See Disease Characteristics More 7 day since prior methotrexate dihydrofolate inhibitor Other More 7 day since prior , concurrent use following : Tricyclic antidepressant ( e.g. , amitriptyline , nortriptyline , desipramine ) Concurrent selective serotonin reuptake inhibitor allow Monoamine oxidase inhibitor Opioid analgesic Anticonvulsants ( e.g. , gabapentin , topiramate , valproic acid , clonazepam ) Adjuvant analgesic ( e.g. , mexiletine ) Prior nonsteroidal antiinflammatory drug allow Topical analgesic ( e.g. , lidocaine gel patch ) affect area Amifostine More 30 day since prior investigational agent pain control No concurrent investigational agent pain control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>neurotoxicity</keyword>
	<keyword>pain</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>